메뉴 건너뛰기




Volumn 65, Issue 6, 2005, Pages 790-791

Charcot-Marie-Tooth disease impairs quality of life: Why? And how do we improve it?

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC DISEASE; CLINICAL FEATURE; DEPRESSION; DISEASE COURSE; EDITORIAL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MENTAL FUNCTION; MIGRAINE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SCORING SYSTEM; SHORT FORM 36;

EID: 25444531406     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000181027.21574.df     Document Type: Editorial
Times cited : (32)

References (10)
  • 1
    • 25444449876 scopus 로고    scopus 로고
    • Quality of life in patients with Charcot Marie Tooth disease
    • Vinci PA, Serrao M, Millul A, et al. Quality of life in patients with Charcot Marie Tooth disease. Neurology 2005;65:922-924.
    • (2005) Neurology , vol.65 , pp. 922-924
    • Vinci, P.A.1    Serrao, M.2    Millul, A.3
  • 2
    • 0033013779 scopus 로고    scopus 로고
    • Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: Problems and solutions
    • Rose MS, Koshman ML, Spreng S, Sheldon R. Statistical issues encountered in the comparison of health-related quality of life in diseased patients to published general population norms: problems and solutions. J Clin Epidemiol 1999;52:405-412.
    • (1999) J Clin Epidemiol , vol.52 , pp. 405-412
    • Rose, M.S.1    Koshman, M.L.2    Spreng, S.3    Sheldon, R.4
  • 3
    • 1942422646 scopus 로고    scopus 로고
    • Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease
    • Passage E, Norreel JC, Noack-Fraissignes P, et al. Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat Med 2004;10:396-401.
    • (2004) Nat Med , vol.10 , pp. 396-401
    • Passage, E.1    Norreel, J.C.2    Noack-Fraissignes, P.3
  • 4
    • 0347185347 scopus 로고    scopus 로고
    • Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A)
    • Sereda MW, Meyer Zu Horste G, Suter U, Uzma N, Nave KA. Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-1A). Nat Med 2003;9:1533-1537.
    • (2003) Nat Med , vol.9 , pp. 1533-1537
    • Sereda, M.W.1    Meyer Zu Horste, G.2    Suter, U.3    Uzma, N.4    Nave, K.A.5
  • 5
    • 25444515903 scopus 로고    scopus 로고
    • Neurotrophin-3 promotes nerve regeneration and improvements in sensory function in CMT1A: Results from animal models and a pilot clinical study
    • in press
    • Sahenk Z, Nagaraja HN, McCracken BS, et al. Neurotrophin-3 promotes nerve regeneration and improvements in sensory function in CMT1A: results from animal models and a pilot clinical study. Neurology 2005 (in press).
    • (2005) Neurology
    • Sahenk, Z.1    Nagaraja, H.N.2    McCracken, B.S.3
  • 6
    • 16844381836 scopus 로고    scopus 로고
    • Reliability and validity of the CMT neuropathy score as a measure of disability
    • Shy ME, Blake J, Krajewski K, et al. Reliability and validity of the CMT neuropathy score as a measure of disability. Neurology 2005;64:1209-1214.
    • (2005) Neurology , vol.64 , pp. 1209-1214
    • Shy, M.E.1    Blake, J.2    Krajewski, K.3
  • 7
    • 0019161221 scopus 로고
    • Human diabetic endoneurial sorbitol, fructose, and myoinositol related to sural nerve morphometry
    • Dyck PJ, Sherman WR, Hallcher LM, et al. Human diabetic endoneurial sorbitol, fructose, and myoinositol related to sural nerve morphometry. Ann Neurol 1980;8:590-596.
    • (1980) Ann Neurol , vol.8 , pp. 590-596
    • Dyck, P.J.1    Sherman, W.R.2    Hallcher, L.M.3
  • 9
    • 0016919875 scopus 로고
    • Subjective measures of well-being
    • Campbell A. Subjective measures of well-being. Am Psychol 1976;31:117-124.
    • (1976) Am Psychol , vol.31 , pp. 117-124
    • Campbell, A.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.